Standout Papers

Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib... 2018 2026 2020 2023 379
  1. Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients (2018)
    Zhe Yang, Nong Yang et al. Clinical Cancer Research

Immediate Impact

4 from Science/Nature 53 standout
Sub-graph 1 of 22

Citing Papers

Electrospun fiber‐based immune engineering in regenerative medicine
2024 Standout
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
10 intermediate papers

Works of Yi Xiang being referenced

In situ inflammatory-regulated drug-loaded hydrogels for promoting pelvic floor repair
2020
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
2018 Standout
and 5 more

Author Peers

Author Last Decade Papers Cites
Yi Xiang 585 510 486 58 1.9k
Di Shi 567 640 769 41 2.0k
Xiaoli Wei 656 374 633 61 2.0k
Gene L. Bidwell 941 296 203 73 2.3k
Akihiko Sano 1283 358 374 151 2.6k
Taiyoun Rhim 723 446 133 67 2.1k
Christian Gorzelanny 588 361 194 62 2.7k
Quan Huang 680 339 300 94 2.2k
Hangyu Zhang 678 165 532 83 1.5k
Xiaolei Tang 655 366 201 114 2.3k
Lia Pulsatelli 469 810 295 80 3.1k

All Works

Loading papers...

Rankless by CCL
2026